Beijing Beilu Pharmaceutical Co., Ltd.

¥7.94As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300016Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (4.46%)
Div yield 1.51%
ROE 6.78%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.40
PE TTM 28.06
TSR TTM (9.82%)
Mkt cap ¥4.619B
ROIC 5.83%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥9.95
25.32%
(44.36%)
Hold 3|2|4|5|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.15
0.16
0.16
0.17
12.27%
5.88%
5.34%
9.77%
Revenue¥M
472.5
470.5
495.2
481.0
6.00%
2.15%
7.07%
4.93%
Peers (US$692.3M)
Cap (US$)
PE
690.6M
69.13x
686.4M
16.18x
684.0M
48.73x
Capital
TTM
5Y
10Y
Leveragex
1.177
—
—
EBIT/Intx
0.545
0.736
0.721
Own earn%
305.54
273.30
234.31
Sh yield%
22.95
38.50
40.74
Owners
Insiders/Inst%
10.55
20.14
Short interest%
2.68
SBC / revenue%
5.40
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
9–15
$1 testx
0.0
Incr. ROIC%
38